SEC Form 4 · accession 0001579824-26-000003
PMV Pharmaceuticals, Inc. · PMVP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles M Baum
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 4:20 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001699382
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.19 | Jun 4, 2026 | A | 42,000 | A | — | Jun 4, 2036 | Common Stock | 42,000 | 42,000 | D |
Explanation of responses
- F1Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders.